Patrick Burnett Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Patrick Burnett is Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 104,811 shares of ARQT, which is worth approximately $2.23 Million. The most recent transaction as insider was on Nov 04, 2024, when has been sold 15,441 shares (Common Stock) at a price of $8.68 per share, resulting in proceeds of $134,027. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K

9.23% 3M change

46.21% 12M change

Total Value Held $2.23 Million

Patrick Burnett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 04 2024	SELL Open market or private sale	$134,027 $8.68 p/Share	15,441 Reduced 7.92%	179,418 Common Stock
Aug 19 2024	SELL Open market or private sale	$14,325 $8.29 p/Share	1,728 Reduced 0.88%	194,859 Common Stock
Aug 02 2024	SELL Open market or private sale	$119,118 $9.02 p/Share	13,206 Reduced 6.29%	196,587 Common Stock
May 30 2024	SELL Open market or private sale	$201,250 $8.75 p/Share	23,000 Reduced 9.88%	209,793 Common Stock
May 30 2024	BUY Exercise of conversion of derivative security	-	23,000 Added 8.99%	232,793 Common Stock
May 29 2024	SELL Open market or private sale	$435,581 $8.72 p/Share	49,952 Reduced 19.23%	209,793 Common Stock
May 02 2024	SELL Open market or private sale	$83,510 $8.74 p/Share	9,555 Reduced 3.55%	259,745 Common Stock
Mar 04 2024	SELL Open market or private sale	$53,175 $11.12 p/Share	4,782 Reduced 1.74%	269,300 Common Stock
Feb 13 2024	BUY Grant, award, or other acquisition	-	189,050 Added 40.82%	274,082 Common Stock
Jan 12 2024	BUY Grant, award, or other acquisition	-	28,000 Added 24.77%	85,032 Common Stock
Jan 02 2024	SELL Open market or private sale	$4,690 $3.54 p/Share	1,325 Reduced 2.27%	57,032 Common Stock
Aug 21 2023	SELL Open market or private sale	$11,315 $7.05 p/Share	1,605 Reduced 2.68%	58,357 Common Stock
Mar 06 2023	SELL Open market or private sale	$12,986 $15.26 p/Share	851 Reduced 1.4%	59,962 Common Stock
Mar 02 2023	SELL Open market or private sale	$28,313 $16.17 p/Share	1,751 Reduced 4.21%	39,813 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	21,000 Added 25.67%	60,813 Common Stock
Jan 03 2023	SELL Open market or private sale	$22,139 $15.01 p/Share	1,475 Reduced 3.43%	41,564 Common Stock
Mar 07 2022	SELL Open market or private sale	$493 $16.44 p/Share	30 Reduced 0.07%	43,039 Common Stock
Mar 04 2022	SELL Open market or private sale	$16,540 $16.86 p/Share	981 Reduced 2.23%	43,069 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	17,800 Added 28.78%	44,050 Common Stock
Dec 30 2021	BUY Grant, award, or other acquisition	-	16,750 Added 38.95%	26,250 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	9,500 Added 50.0%	9,500 Common Stock

Patrick Burnett

Officer

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account